Cancer Advocates Requested Increased Federal Funding

Over 750 advocates visited Capitol Hill to push for expanded research and cancer prevention resources.

Updated on Sept. 29, 2026 in Cancer

Bold flat-color editorial illustration of the US Capitol dome, representing federal policy advocacy and legislative lobbying efforts. — Cancer advocates visited Capitol Hill this week to lobby for $51.3 billion in NIH funding and the passage of the Clinical Trial Modernization Act. AI Illustration. Upload story photo >

Live Poll

Should the federal government increase its annual spending on cancer research and prevention?

More than 750 cancer patients and advocates traveled to Capitol Hill to request $51.3 billion for the National Institutes of Health. The group also lobbied for the passage of the Clinical Trial Modernization Act to reduce financial barriers to care.

Why it matters

The advocacy efforts aim to bolster federal research and prevention programs that directly support patients across the country. By requesting $230 million for breast and cervical cancer programs, advocates hope to improve detection and patient outcomes.

Advocates requested $51.3 billion for the NIH and $230 million for breast and cervical cancer prevention. This follows data showing nearly 37,000 annual cancer diagnoses and 12,000 cancer-related deaths in South Carolina.

The players

American Cancer Society Cancer Action Network

This is the nonpartisan advocacy affiliate of the American Cancer Society that focuses on developing and executing legislative campaigns.

The details

Organized by the American Cancer Society Cancer Action Network, the participants held direct meetings with lawmakers to demand policy changes. These sessions focused on improving access to clinical trials and addressing systemic financial challenges faced by patients.

September 29, 2026: Advocates met with lawmakers on Capitol Hill.

The Big Picture

The push for the Clinical Trial Modernization Act follows a pattern of legislative efforts aimed at systemic healthcare reform. This initiative represents a strategic attempt to lower barriers to entry for clinical trials, mirroring historical policy shifts in federal health research.

The requested $230 million for prevention programs could expand access to early screenings and diagnostic services for residents across South Carolina. Legislative changes to clinical trials may eventually lower the financial costs associated with experimental treatments for patients.

The takeaway

Legislative advocacy remains a critical driver for shifts in federal health budgets and clinical trial accessibility. Patients and families can track the progress of these funding requests by following updates on the National Institutes of Health budgetary process.